- Home
- MOLN vs MVST Comparison
MOLN vs MVST Comparison
Compare MOLN & MVST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MOLN | MVST |
|---|---|---|
| Founded | 2004 | 2006 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | | Industrial Machinery/Components |
| Sector | | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 164.2M | 918.9M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | MOLN | MVST |
|---|---|---|
| Price | $4.22 | $2.84 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $3.75 | ★ $6.00 |
| AVG Volume (30 Days) | 3.9K | ★ 4.3M |
| Earning Date | 02-11-2026 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $444,504,000.00 |
| Revenue This Year | N/A | $24.19 |
| Revenue Next Year | $999.99 | $17.70 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 19.82 |
| 52 Week Low | $3.36 | $1.09 |
| 52 Week High | $5.91 | $7.12 |
Technical Indicators
Market Signals| Indicator | MOLN | MVST |
|---|---|---|
| Relative Strength Index (RSI) | 48.42 | 34.30 |
| Support Level | $4.16 | $2.73 |
| Resistance Level | $4.44 | $3.16 |
| Average True Range (ATR) | 0.18 | 0.16 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 44.12 | 15.57 |
Price Performance
Historical ComparisonAbout MOLN Molecular Partners AG
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.
About MVST Microvast Holdings Inc.
Microvast Holdings Inc is a technology innovator that designs, develops, and manufactures lithium-ion battery solutions. It is renowned for its cutting-edge cell technology and its vertical integration capabilities which extends from core battery chemistry to battery packs.